Compile Data Set for Download or QSAR
Report error Found 253 Enz. Inhib. hit(s) with all data for entry = 8601
TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406539(3-[5-(1H-1,2,3- benzotriazol-1- ylmethyl)-1,3,4- o...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406540(5-(2,6- dimethoxyphenyl)- 6-(ethoxymethyl)- 3-[5-(...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406541(5-(2,6- dimethoxyphenyl)- 6-(ethoxymethyl)- 3-{5-[...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406537(5-(2,6- dimethoxyphenyl)- 6-(ethoxymethyl)- 3-{5-[...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406538(5-(2,6- dimethoxyphenyl)- 6-(ethoxymethyl)- 3-[5-(...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406532(5-(2,6- dimethoxyphenyl)- 6-(ethoxymethyl)- 3-{5-[...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406533(3-{5-[(5- chloropyridin-2- yl)methyl]-1,3,4- oxadi...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406534(5-(2,6- dimethoxyphenyl)- 6-(ethoxymethyl)- 3-{5-[...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406528(3-{5-[(4-chloro-3- fluorophenyl) methyl]-1,3,4- ox...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406529(3-{5-[(4-chloro-2- fluorophenyl) methyl]-1,3,4- ox...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406530(5-(2,6- dimethoxyphenyl)- 6-(ethoxymethyl)- 3-{5-[...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406555(6-butyl-5-(3- cyclopropylphenyl)- 4-hydroxy-3-{5- ...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406556(6-butyl-4-hydroxy- 5-(3- methoxyphenyl)-3- {5-[(2-...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406553(6-butyl-4-hydroxy- 3-{5-[(2-methyl- 1,3-thiazol-4-...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406554(3-(2-butyl-4- hydroxy-5-{5-[(2- methyl-1,3-thiazol...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406548(6-butyl-3-{5-[(3,4- difluorophenyl) methyl]-1,3,4-...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406571(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406572(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406574(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406567(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406568(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406569(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406570(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406563(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406564(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406565(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406566(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406559(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406560(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406561(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406562(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406588(N-benzyl-2-{5-[6- butyl-5-(2,6- dimethoxyphenyl)- ...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406589(2-{5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dihy...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406590(2-{5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dihy...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406583(2-{5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dihy...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406584(2-{5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dihy...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406586(4-(2-{5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- d...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406581(2-{5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dihy...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406575(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406576(N-({5-[5-(2,6- dimethoxyphenyl)- 6-(ethoxymethyl)-...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406577(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406578(N-({5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dih...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406603(2-{5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dihy...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406605(6-butyl-5-(2,6- dimethoxyphenyl)- 3-(5-{[5-(pyridi...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406606(6-butyl-5-(2,6- dimethoxyphenyl)- 3-(5-{[5-(pyridi...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406599(N-butyl-2-{5-[6- butyl-5-(2,6- dimethoxyphenyl)- 2...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406601(2-{5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dihy...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406602(2-{5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dihy...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406596(2-{5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dihy...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406597(2-{5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4- dihy...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

Displayed 1 to 50 (of 253 total ) | Next | Last >>
Jump to: